RELIEF THERAPEUTICS Holding SA announced positive 12-month stability data for the liquid and lyophilized preparations of RLF-100 ®, intended for intravenous and inhaled administration.
RELIEF THERAPEUTICS Holding SA announced positive 12-month stability data for the liquid and lyophilized preparations of RLF-100 ®, intended for intravenous and inhaled administration.